Navigation Links
Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
Date:12/3/2008

peutic as a single agent for patients with Stage III or IV metastatic melanoma. Based on advice from clinical experts and detailed guidance received from the U.S. Food and Drug Administration (FDA) in an End-of-Phase 2 meeting, Vical successfully completed a Special Protocol Assessment (SPA) with the FDA for a Phase 3 trial (the Allovectin-7(R) Immunotherapeutic for Metastatic Melanoma, or AIMM trial) for certain patients with Stage III or Stage IV metastatic melanoma. The SPA agreement specifies that the trial design and planned analyses address the study's objectives and the resulting study data could provide the primary basis to support a product license application.

Allovectin-7(R) has been granted orphan drug designation for the treatment of invasive and metastatic melanoma by the FDA's Office of Orphan Products Development. Orphan drug designation provides U.S. marketing exclusivity for seven years if marketing approval is received from the FDA, in addition to certain tax benefits for qualifying expenses.

About the AIMM Trial

Vical is conducting a Phase 3 pivotal trial of the company's Allovectin-7(R) cancer immunotherapeutic as first-line therapy in chemotherapy-naive patients with Stage III or IV metastatic melanoma. The AIMM trial is being conducted in accordance with the SPA agreement at more than 60 clinical sites, and is currently enrolling patients in the United States, Canada and Europe. AnGes MG, Inc., is funding the clinical trial under a collaborative agreement with Vical.

The AIMM trial calls for enrollment of approximately 375 patients with Stage III or IV metastatic melanoma. Patients may have been previously treated with surgery, adjuvant therapy, and/or biotherapy, but cannot have been previously treated with cytotoxic chemotherapy. The patients will be randomized on a 2:1 basis: approximately 250 patients will be treated with Allovectin-7(R) and approximately 125
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
2. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
3. U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vicals Vaxfectin(R) Adjuvant
4. Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months
5. First Published Study of New HPV Test for Developing Countries Shows High Accuracy in Predicting Cervical Disease
6. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
7. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
8. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
9. Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
10. Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
11. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014  Luoxis Diagnostics, Inc., a subsidiary of ... that its academic collaborators will present several peer-reviewed ... its novel RedoxSYS Diagnostic System, a first-in-class platform ... in response to injury or illness.  A poster ... clinical marker will be presented by Christopher ...
(Date:10/20/2014)... -- Valeritas, Inc., a leader in simple, disposable basal-bolus ... diabetes, announced today that it has received a 2014 ... presented October 16 th at Cardinal,s annual Business ... The Cardinal Health Supply Chain Excellence ... specifically targeted at the importance of developing collaborative relationships ...
(Date:10/20/2014)... SAN DIEGO , Oct. 20, 2014 /PRNewswire/ ... development of therapeutic antibodies, today announced the appointment ... Development Officer. Dr. Londei will lead the preclinical ... "We are pleased to welcome ... Hamza Suria , President and Chief Executive ...
Breaking Medicine Technology:Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 2Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 4Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 5Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2
... The largest natural allograft available on the market today for ... Musculoskeletal Transplant Foundation (MTF), the nation,s leading provider of allograft ... sized grafts of FlexHD®, their hydrated acellular dermal matrix, just ... These two new sizes are the largest allografts ...
... NEW YORK, Nov. 16, 2010 Reportlinker.com announces that ... catalogue: Global Blood Glucose Meters ... This report analyzes the worldwide ... Million by the following Product Segments: Blood Glucose Strips, ...
Cached Medicine Technology:Largest Acellular Dermal Allografts for Abdominal Wall Repair Now Available From MTF 2Reportlinker Adds Global Blood Glucose Meters and Strips Industry 2Reportlinker Adds Global Blood Glucose Meters and Strips Industry 3Reportlinker Adds Global Blood Glucose Meters and Strips Industry 4Reportlinker Adds Global Blood Glucose Meters and Strips Industry 5Reportlinker Adds Global Blood Glucose Meters and Strips Industry 6Reportlinker Adds Global Blood Glucose Meters and Strips Industry 7Reportlinker Adds Global Blood Glucose Meters and Strips Industry 8Reportlinker Adds Global Blood Glucose Meters and Strips Industry 9Reportlinker Adds Global Blood Glucose Meters and Strips Industry 10Reportlinker Adds Global Blood Glucose Meters and Strips Industry 11Reportlinker Adds Global Blood Glucose Meters and Strips Industry 12Reportlinker Adds Global Blood Glucose Meters and Strips Industry 13Reportlinker Adds Global Blood Glucose Meters and Strips Industry 14Reportlinker Adds Global Blood Glucose Meters and Strips Industry 15Reportlinker Adds Global Blood Glucose Meters and Strips Industry 16Reportlinker Adds Global Blood Glucose Meters and Strips Industry 17Reportlinker Adds Global Blood Glucose Meters and Strips Industry 18Reportlinker Adds Global Blood Glucose Meters and Strips Industry 19Reportlinker Adds Global Blood Glucose Meters and Strips Industry 20Reportlinker Adds Global Blood Glucose Meters and Strips Industry 21Reportlinker Adds Global Blood Glucose Meters and Strips Industry 22Reportlinker Adds Global Blood Glucose Meters and Strips Industry 23Reportlinker Adds Global Blood Glucose Meters and Strips Industry 24Reportlinker Adds Global Blood Glucose Meters and Strips Industry 25
(Date:10/20/2014)... Myoderm announced today the ... their CentralSource service. Matthew will play ... drug sourcing, distribution, and management service for international ... of industry experience, in both business development and ... their international success to help clients manage their ...
(Date:10/20/2014)... 2014 Final Cut Pro X Plugin developers ... Citrus theme for FCPX filmmakers . , “Fun, cool, ... the Citrus theme” Says Christina Austin, CEO of Pixel Film ... professional.” , Citrus comes with all the tools needed for ... four transitions for added style, a title screen for an ...
(Date:10/20/2014)... 2014 Do you ever feel difficulty ... a wonderful app Metassessor for teachers, specialists and parents. ... helped its client “Intervention Development LLC” to launch Metassessor ... designed for iOS 4.3 or later and is Compatible ... optimized for iPhone 5. It is now available on ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 This ... for Partial Seizure, complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ... news and press releases. It also reviews key ... Seizure and special features on late-stage and discontinued ...
(Date:10/19/2014)... Charlotte, NC (PRWEB) October 19, 2014 ... muscle building program has just been released to ... throughout the online body building and fitness community. ... the attention of DietsAndFitnessGuides.com's Vin Delmonico prompting an ... the experience of hitting what is commonly known ...
Breaking Medicine News(10 mins):Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2
... more procedures to reopen arteries, study found , , MONDAY, ... in the left main coronary artery, percutaneous coronary intervention ... be a viable alternative to bypass surgery. , "We ... PCI and surgery," Dr. Seung-Jung Park, senior author of ...
... N.J., March 31 The Palace was the backdrop,for ... Council,(NJTC) crowned the "Best in Show" at the 2008 ... Most Likely to Succeed" and,Switch2Health of New Brunswick took ... event drew a crowd of more than 500 entrepreneurs,and ...
... is available in French . , Montreal, March ... has identified a novel gene responsible for a significant fraction ... referred to as Lou Gehrigs disease, an incurable neuromuscular disorder ... within one to five years. , Published in the current ...
... 2, ,Kick Butts Day, at 11 a.m. in Kettering, ... youth leaders from Ohio will hold a press conference ... describes how tobacco,companies take advantage of the lack of ... products aimed at hooking kids and,preventing current smokers from ...
... New Artis zee Family Provides Interventional Cardiologists with Enhanced ... Imaging for Faster, More Precise Procedures, CHICAGO, ... ranks as America,s No. 1 killer,with an average of one ... the obesity epidemic have contributed to the surge of,Americans with ...
... Alseres,Pharmaceuticals, Inc. (Nasdaq: ALSE ) ... independent registered public accounting firm regarding the,Company,s ... the Company,s ability to continue as a ... to publicly announce if,their Annual Report on ...
Cached Medicine News:Health News:Angioplasty Proves Reasonable Alternative to Bypass Surgery 2Health News:Technology Shines at 2008 NJTC Venture Conference; 'Best in Show' Winners Announced 2Health News:Technology Shines at 2008 NJTC Venture Conference; 'Best in Show' Winners Announced 3Health News:Researchers identify a gene responsible for Lou Gehrig's disease 2Health News:Ohio Faith Leaders Call on Sen. Voinovich to Cosponsor Legislation to Protect Kids From Tobacco 2Health News:See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 2Health News:See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 3Health News:See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 4Health News:Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K 2Health News:Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K 3
Six inch wide elastic belt transfers the apron weight off the shoulders. 0.5mm front and 0.25mm back with a generous overlap for double protection. Shoulder pads included. Also available without wide...
Front protection with choice of adjustable 2" buckle or velcro belt which crosses the back for a comfortable fit. Adjustable straps at shoulders keeps apron snug....
... pocket-size peripheral nerve stimulator ... full-function nerve locator or ... depending upon which patient ... Includes NSL-5 electrode lead ...
Low pressure automatic tourniquet with manual time. Includes extension hose and spiral replacement hose....
Medicine Products: